Search - tctmd.com

Displaying 81 - 100 of 628

Sort: Relevancy | Date

News Daily News

Clopidogrel Superior to ‘Divine’ Aspirin Monotherapy in Secondary Prevention

Michael O'Riordan

March 30, 2022

News Daily News

REMAP-CAP: Mixed Results for Antiplatelets in Critical COVID-19

Todd Neale

March 22, 2022

News Daily News

No Stents in STEMI? With Careful Selection, Maybe

Caitlin E. Cox

March 21, 2022

News Opinion CV Team Dispatch

March 2022 News Roundup

L.A. McKeown

March 01, 2022

News Daily News

Another Win for Guided P2Y12 Therapy in ACS: Meta-analysis

Yael L. Maxwell

December 24, 2021

News Daily News

Still No Edge for Bivalirudin in VALIDATE-SWEDEHEART’s STEMI Patients

Shelley Wood

December 22, 2021

News Daily News

TCTMD’s Top 10 Most Popular Stories for November 2021

Shelley Wood

November 30, 2021

News Conference News AHA 2021

No Benefit for Icosapent Ethyl, P2Y12 Inhibitors in Separate COVID-19 Trials

Todd Neale

November 15, 2021

News Conference News AHA 2021

Bentracimab Rapidly, Safely Reverses Ticagrelor in Early REVERSE-IT Data

Yael L. Maxwell

November 15, 2021

News Conference News AHA 2021

RAPID CABG: No Penalty to Early Surgery for ACS After Stopping Ticagrelor

Yael L. Maxwell

November 13, 2021

News Opinion Editor's Corner AHA 2021

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

Shelley Wood

November 08, 2021

News Conference News TCT 2021

Magnetic Endoscopy Capsule Reveals GI Damage Surprises From Antiplatelets

Caitlin E. Cox

November 06, 2021

News Conference News TCT 2021

OCT Guidance Cuts Stent Use in STEMI Without Plaque Rupture: EROSION III

Shelley Wood

November 04, 2021

Podcast TCTMD Talking Points

The TICO-STEMI Trial

October 06, 2021

News Daily News

Lidocaine Less Likely Than Fentanyl to Blunt P2Y12 Inhibitors in the Cath Lab

L.A. McKeown

September 07, 2021

News Conference News ESC 2021

Prasugrel Tops Ticagrelor in ACS Across the eGFR Spectrum: ISAR-REACT 5

Todd Neale

August 24, 2021

News Daily News

De-escalation Tops Other DAPT Tactics for ACS: Meta-analysis

Yael L. Maxwell

July 16, 2021

News

Tastes Like Ticagrelor: Mouth-Dissolving Pills Match Standard Ones in ACS

Yael L. Maxwell

July 13, 2021

News Daily News

ISAR-REACT 5: Subanalysis of PCI Patients Confirms Prasugrel Superiority

Yael L. Maxwell

July 01, 2021

Crushing Prasugrel Tabs Ups Platelet Inhibition Following Primary PCI

News Daily News

Crushed Prasugrel in the Ambulance Ups Platelet Inhibition in Primary PCI

Yael L. Maxwell

June 22, 2021

Advertisement

Clopidogrel Superior to ‘Divine’ Aspirin Monotherapy in Secondary Prevention

REMAP-CAP: Mixed Results for Antiplatelets in Critical COVID-19

No Stents in STEMI? With Careful Selection, Maybe

March 2022 News Roundup

Another Win for Guided P2Y12 Therapy in ACS: Meta-analysis

Still No Edge for Bivalirudin in VALIDATE-SWEDEHEART’s STEMI Patients

TCTMD’s Top 10 Most Popular Stories for November 2021

No Benefit for Icosapent Ethyl, P2Y12 Inhibitors in Separate COVID-19 Trials

Bentracimab Rapidly, Safely Reverses Ticagrelor in Early REVERSE-IT Data

RAPID CABG: No Penalty to Early Surgery for ACS After Stopping Ticagrelor

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

Magnetic Endoscopy Capsule Reveals GI Damage Surprises From Antiplatelets

OCT Guidance Cuts Stent Use in STEMI Without Plaque Rupture: EROSION III

The TICO-STEMI Trial

Lidocaine Less Likely Than Fentanyl to Blunt P2Y12 Inhibitors in the Cath Lab

Prasugrel Tops Ticagrelor in ACS Across the eGFR Spectrum: ISAR-REACT 5

De-escalation Tops Other DAPT Tactics for ACS: Meta-analysis

Tastes Like Ticagrelor: Mouth-Dissolving Pills Match Standard Ones in ACS

ISAR-REACT 5: Subanalysis of PCI Patients Confirms Prasugrel Superiority

Crushed Prasugrel in the Ambulance Ups Platelet Inhibition in Primary PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content